New home construction plunged 14% in December 2007 to a seasonally-adjusted annual rate of 1.01 million units, below the 1.14-million-unit consensus estimate, and the slowest pace in 16 years, the U.S. Commerce Department announced Thursday (pdf). Further, for 2007, new home construction fell 25% to 1.35 million units -- the lowest total since 1993.
Economist Steve Affinito told BloggingStocks Thursday December 2007's new home construction statistic closes out a difficult year for housing, to say the least.
Very weak statistic
"It's a very weak stat, one that confirms the housing sector's deep correction in 2007," Affinito said. "It indicates that builders pulled-back considerably in the face of an oversupply of new homes, and the inability of the market to work-off sales of existing homes."
Affinito added that he expected the housing sector to "take at least 1 percentage point off U.S. GDP in 2008." The earliest possible recovery quarter for the housing sector is Q1 2009 or Q2 2009, Affinito said.
On a year-over-year basis, housing starts are down 38%, the nation's biggest housing start slump since 1980.
Meanwhile, building permits, an indicator economists and analysts use to gauge future housing activity, fell 8% in December 2007 to a seasonally-adjusted rate of 1.07 million, the Commerce Department said. Single family home building permits fell 10% in December 2007 to 692,000 and fell 29% in 2007 to 1.05 million -- the lowest total since 1992.
Last updated: February 13, 2012: 09:59 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Airlines the Latest to Suffer Euro Crisis Blues
- Internet-Hungry Consumers Force Vodafone to Consider a C&W Offer
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
TheFlyOnTheWall.com Headlines
- SanDisk volatility low into analyst day and sales outlook
- Obama budget requests increase in Pell Grants, Inside Higher Education says
- Stoneridge sees 2012 EPS $1.10-$1.30 vs. consensus $1.13
- Stoneridge Q2 results include $1.72/sh in gains
- Stoneridge reports Q4 diluted EPS $1.56 vs. consensus 22c
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

